Sleep Medicine Reviews
Volume 14, Issue 4 , Pages 259-267 , August 2010

Effect of hypnotic drugs on body balance and standing steadiness

Received 20 May 2009 ,Revised 22 October 2009 ,Accepted 22 October 2009.

References∗ 

  1. Campbell AJ, Borrie MJ, Spears GF, Jackson SL, Brown JS, Fitzgerald JL. Circumstances and consequences of falls experienced by a community population 70 years and over during a prospective study. Age Ageing. 1990;19(2):136–141
  2. Horak FB. Postural orientation and equilibrium: what do we need to know about neural control of balance to prevent falls?. Age Ageing. 2006 Sep;35(Suppl. 2):ii7–ii11
  3. Wolinsky FD, Fitzgerald JF, Stump TE. The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study. Am J Public Health. 1997 Mar;87(3):398–403
  4. Kirke PN, Sutton M, Burke H, Daly L. Outcome of hip fracture in older Irish women: a 2-year follow-up of subjects in a case-control study. Injury. 2002 Jun;33(5):387–391
  5. Empana JP, Dargent-Molina P, Breart G EPIDOS Group. Effect of hip fracture on mortality in elderly women: the EPIDOS prospective study. J Am Geriatr Soc. 2004 May;52(5):685–690
  6. Bloem BR, Steijns JA, Smits-Engelsman BC. An update on falls. Curr Opin Neurol. 2003 Feb;16(1):15–26
  7. Rubenstein LZ, Powers CM, MacLean CH. Quality indicators for the management and prevention of falls and mobility problems in vulnerable elders. Ann Intern Med. 2001 Oct 16;135(8 Pt 2):686–693
  8. Passaro A, Volpato S, Romagnoni F, Manzoli N, Zuliani G, Fellin R. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell'Anziano. J Clin Epidemiol. 2000 Dec;53(12):1222–1229
  9. Allain H, Bentue-Ferrer D, Polard E, Akwa Y, Patat A. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging. 2005;22(9):749–765
  10. Evans SM, Funderburk FR, Griffiths RR. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther. 1990 Dec;255(3):1246–1255
  11. Farre M, Teran MT, Cami J. A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers. Psychopharmacology (Berl). 1996 May;125(1):1–12
  12. Rush CR, Baker RW, Wright K. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans. Psychopharmacology (Berl). 1999 Jun;144(3):220–233
  13. Rush CR, Frey JM, Griffiths RR. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential. Psychopharmacology (Berl). 1999 Jul;145(1):39–51
  14. Simpson CA, Rush CR. Acute performance-impairing and subject-rated effects of triazolam and temazepam, alone and in combination with ethanol, in humans. J Psychopharmacol. 2002 Mar;16(1):23–34
  15. Farre M, Teran MT, Roset PN, Mas M, Torrens M, Cami J. Abuse liability of flunitrazepam among methadone-maintained patients. Psychopharmacology (Berl). 1998 Dec;140(4):486–495
  16. Rush CR, Griffiths RR. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers. J Clin Psychopharmacol. 1996 Apr;16(2):146–157
  17. Kirk T, Roache JD, Griffiths RR. Dose–response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects. J Clin Psychopharmacol. 1990 Jun;10(3):160–167
  18. Johnson MW, Suess PE, Griffiths RR. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Arch Gen Psychiatry. 2006 Oct;63(10):1149–1157
  19. Wright BM. A simple mechanical ataxiameter. J Physiol. 1971 Oct;218(1):27P–28P
  20. Lord SR, Clark RD, Webster IW. Postural stability and associated physiological factors in a population of aged persons. J Gerontol. 1991;46(3):M69–M76
  21. Di Fabio RP. Meta-analysis of the sensitivity and specificity of platform posturography. Arch Otolaryngol Head Neck Surg. 1996;122:150–156
  22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996 Feb;17(1):1–12
  23. Vermeeren A, Danjou PE, O'Hanlon JF. Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20mg on memory and actual driving performance. Hum Psychopharmacol. 1998;13(Suppl. 2):S98–S107
  24. Whitmore JN, Fischer JR, Barton EC, Storm WF. Performance following a sudden awakening from daytime nap induced by zaleplon. Aviat Space Environ Med. 2004 Jan;75(1):29–36
  25. Berlin I, Warot D, Hergueta T, Molinier P, Bagot C, Puech AJ. Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol. 1993 Apr;13(2):100–106
  26. Nakamura M, Ishii M, Niwa Y, Yamazaki M, Ito H. Temporal changes in postural sway caused by ultrashort-acting hypnotics: triazolam and zolpidem. ORL J Otorhinolaryngol Relat Spec. 2005;67(2):106–112
  27. Allain H, Patat A, Lieury A, Le Coz F, Janus C, Menard G, et al. Comparative study of the effects of zopiclone (7.5mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics. Eur Psychiatry. 1995;10(Suppl. 3):129s–135s
  28. Mattila MJ, Vanakoski J, Kalska H, Seppala T. Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Pharmacol Biochem Behav. 1998 Apr;59(4):917–923
  29. Tada K, Sato Y, Sakai T, Ueda N, Kasamo K, Kojima T. Effects of zopiclone, triazolam, and nitrazepam on standing steadiness. Neuropsychobiology. 1994;29(1):17–22
  30. Mattila MJ, Vanakoski J, Mattila-Evenden ME, Karonen SL. Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects. Eur J Clin Pharmacol. 1994;46(3):215–220
  31. Nikaido AM, Ellinwood EH. Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance. Psychopharmacology (Berl). 1987;92(4):459–464
  32. Swift CG, Swift MR, Ankier SI. Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly. Br J Clin Pharmacol. 1985;20(2):119–128
  33. Norris V, Baisley KJ, Calder N, Van Troostenburg A, Warrington SJ. Assessment of the AccuSwayPLUS system in measuring the effect of lorazepam on body sway in healthy volunteers. Int J Pharm Med. 2005;19(4):233–238
  34. Roth T, Piccione P, Salis P, Kramer M, Kaffeman M. Effects of temazepam, flurazepam and quinalbarbitone on sleep: psychomotor and cognitive function. Br J Clin Pharmacol. 1979;8(1):47S–54S
  35. Swift CG, Haythorne JM, Clarke P, Stevenson IH. The effect of ageing on measured responses to single doses of oral temazepam. Proc BPS. 1980;413P–414P
  36. Briggs RS, Castleden CM, Kraft CA. Improved hypnotic treatment using chlormethiazole and temazepam. Br Med J. 1980 Mar 1;280(6214):601–604
  37. Tazaki T, Tada K, Nogami Y, Takemura N, Ishikawa K. Effects of butoctamide hydrogen succinate and nitrazepam on psychomotor function and EEG in healthy volunteers. Psychopharmacology (Berl). 1989;97(3):370–375
  38. Castleden CM, Allen JG, Altman J, St John-Smith P. A comparison of oral midazolam, nitrazepam and placebo in young and elderly subjects. Eur J Clin Pharmacol. 1987;32(3):253–257
  39. Robin DW, Lee M, Hasan SS, Wood AJ. Triazolam in cirrhosis: pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 1993 Dec;54(6):630–637
  40. Robin DW, Hasan SS, Lichtenstein MJ, Shiavi RG, Wood AJ. Dose-related effect of triazolam on postural sway. Clin Pharmacol Ther. 1991 May;49(5):581–588
  41. Kinirons MT, Lang CC, He HB, Ghebreselasie K, Shay S, Robin DW, et al. Triazolam pharmacokinetics and pharmacodynamics in Caucasians and Southern Asians: ethnicity and CYP3A activity. Br J Clin Pharmacol. 1996 Jan;41(1):69–72
  42. Hege SG, Ellinwood EH, Wilson WH, Helligers CAM, Graham SM. Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam. Psychopharmacology. 1997;131(2):101–107
  43. de Haas SL, de Visser SJ, van der Post JP, de Smet M, Schoemaker RC, Rijnbeek B, et al. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers. J Psychopharmacol. 2007 Jun;21(4):374–383
  44. van der Post J, Schram MT, Schoemaker RC, Pieters MS, Fuseau E, Pereira A, et al. CNS effects of sumatriptan and rizatriptan in healthy female volunteers. Cephalalgia. 2002 May;22(4):271–281
  45. Hindmarch I. Some aspects of the effects of clobazam on human psychomotor performance. Br J Clin Pharmacol. 1979;7(Suppl. 1):77S–82S
  46. Sturnieks DL, St George R, Lord SR. Balance disorders in the elderly. Neurophysiol Clin. 2008 Dec;38(6):467–478
  47. Allain H, Tessier C, Bentue-Ferrer D, Tarral A, Le Breton S, Gandon JM, et al. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers. Psychopharmacology. 2003;165(4):419–429
  48. Patat A, Alberini H, Bonhomme D, Soubrane C, Allain H, Gandon JM. Effects of tiapride on electroencephalograms and cognitive functions in the elderly. Int Clin Psychopharmacol. 1999 Jul;14(4):199–208
  49. Vanakoski J, Seppala T, Stromberg C, Naveri L, Hammett J, Ford N. Effects of ceronapril alone or in combination with alcohol on psychomotor performance in healthy volunteers: a placebo-controlled, crossover study. Curr Ther Res Clin Exp. 2001;62:699–708
  50. Allain H, Bentue-Ferrer D, Tarral A, Gandon JM. Effects on postural oscillation and memory functions of a single dose of zolpidem 5mg, zopiclone 3.75mg and lormetazepam 1mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo. Eur J Clin Pharmacol. 2003 Jul;59(3):179–188
  51. Boyle J, Wolford D, Gargano C, McCrea J, Cummings C, Cerchio K, et al. Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects. Br J Clin Pharmacol. 2008;67(2):180–190
  52. Zammit G, Wang-Weigand S, Peng X. Use of computerized dynamic posturography to assess balance in older adults after nighttime awakenings using zolpidem as a reference. BMC Geriatr. 2008 Jul 15;8:15
  53. Boyle J, Wolford D, Gargano C, McCrea J, Cummings C, Cerchio K, et al. Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects. Hum Psychopharmacol. 2009 Jan;24(1):61–71
  54. Robin DW, Hasan SS, Edeki T, Lichtenstein MJ, Shiavi RG, Wood AJ. Increased baseline sway contributes to increased losses of balance in older people following triazolam. J Am Geriatr Soc. 1996 Mar;44(3):300–304
  55. Campbell AJ, Somerton DT. Benzodiazepine drug effect on body sway in elderly subjects. J Clin Exp Gerontol. 1982;4(4):341–347
  56. Muraoka M, Tada K, Nogami Y, Ishikawa K, Nagoya T. Residual effects of repeated administration of triazolam and nitrazepam in healthy volunteers. Neuropsychobiology. 1992;25(3):134–139
  57. Mattila MJ, Aranko K, Mattila ME, Stromberg C. Objective and subjective assessment of hangover during subacute administration of temazepam and nitrazepam to healthy subjects. Eur J Clin Pharmacol. 1984;26(3):375–380
  58. Patat A, Foulhoux P. Effect on postural sway of various benzodiazepine tranquillizers. Br J Clin Pharmacol. 1985 Jul;20(1):9–16
  59. Mamelak M, Csima A, Buck L, Price V. A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly. J Clin Psychopharmacol. 1989 Aug;9(4):260–267
  60. Van Steveninck AL, Wallnofer AE, Schoemaker RC, Pieters MS, Danhof M, van Gerven JM, et al. A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population. Br J Clin Pharmacol. 1997 Sep;44(3):267–275
  61. Abanades S, Farre M, Barral D, Torrens M, Closas N, Langohr K, et al. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users. J Clin Psychopharmacol. 2007 Dec;27(6):625–638
  62. Kuitunen T, Mattila MJ, Seppala T. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. Int Clin Psychopharmacol. 1990 Apr;5(Suppl. 2):115–130
  63. Hill SY, Goodwin DW, Reichman JB, Mendelson WB, Hopper S. A comparison of two benzodiazepine hypnotics administered with alcohol. J Clin Psychiatry. 1982 Oct;43(10):408–410
  64. Aranko K, Seppala T, Pellinen J, Mattila MJ. Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses. Eur J Clin Pharmacol. 1985;28(5):559–565
  65. Seppala T, Aranko K, Mattila MJ, Shrotriya RC. Effects of alcohol on buspirone and lorazepam actions. Clin Pharmacol Ther. 1982 Aug;32(2):201–207
  66. Seppala T, Nuotto E, Dreyfus JF. Drug–alcohol interactions on psychomotor skills: zopiclone and flunitrazepam. Pharmacology. 1983;27(Suppl. 2):127–135
  67. Kuitunen T, Mattila MJ, Seppala T, Aranko K, Mattila ME. Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. Br J Clin Pharmacol. 1990 Sep;30(3):453–461
  68. Patat A, Perault MC, Vandel B, Danjou P, Brohier S, Zieleniuk I, et al. Assessment of the interaction between a partial agonist and a full agonist of benzodiazepine receptors, based on psychomotor performance and memory, in healthy volunteers. J Psychopharmacol. 1995;9(2):91–101
  69. Patat A, Perault MC, Vandel B, Ulliac N, Zieleniuk I, Rosenzweig P. Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers. Br J Clin Pharmacol. 1995 Jan;39(1):31–38
  70. Perault MC, Bergougnan L, Paillat A, Zieleniuk I, Rosenzweig P, Vandel B. Lack of interaction between amisulpride and lorazepam on psychomotor performance and memory in healthy volunteers. Hum Psychopharmacol. 1998;13(7):493–500
  71. Piirtola M, Era P. Force platform measurements as predictors of falls among older people – a review. Gerontology. 2006;52(1):1–16
  72. Verster JC, Veldhuijzen DS, Volkerts ER. Residual effects of sleep medication on driving ability. Sleep Med Rev. 2004 Aug;8(4):309–325
  73. Alpini D, Cesarani A, Fraschini F, Kohen-Raz R, Capobianco S, Cornelio F. Aging and vestibular system: specific tests and role of melatonin in cognitive involvement. Arch Gerontol Geriatr Suppl. 2004;9:13–25
  74. Buatois S, Gueguen R, Gauchard GC, Benetos A, Perrin P. Posturography and risk of recurrent falls in healthy non-institutionalized persons aged over 65. Gerontology. 2006;52:345–352
  75. Overstall PW, Exton-Smith AN, Imms FJ, Johnson AL. Falls in the elderly related to postural imbalance. BMJ. 1977;1:261–264
  76. Masui T, Hasegawa Y, Matsuyama Y, Sakano S, Kawasaki M, Suzuki S. Gender differences in platform measures of balance in rural community-dwelling elders. Arch Gerontol Geriatr. 2005;41:201–209

PII: S1087-0792(09)00118-X

doi: 10.1016/j.smrv.2009.10.008

Sleep Medicine Reviews
Volume 14, Issue 4 , Pages 259-267 , August 2010

Article Tools

* Image Usage & Resolution